Browsing bySubjectProstate cancer

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
가 나 다 라 마 바 사 아 자 차 카 타 파 하
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 16 of 16

Issue DateTitleAuthor(s)Type
2026Active surveillance could apply to one-quarter of Korean prostate cancer cases: Insights from a 27,075-patient cohort고영휘Article
2021Androgen deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: a nationwide population-based cohort study안현규Article
2015Body concentrations of persistent organic pollutants and prostate cancer: a meta-analysis박혜숙Article
2025Changes in proteinuria and the risk of urogenital cancer in Korean men하은희Article
2025Establishing consensus recommendations for metastatic hormone-sensitive prostate cancer in South Korea: A modified Delphi study김광현Article
2017Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee이동현Article
2026Impact of repeated prostate-specific antigen testing on management patterns and personal healthcare spending for prostate cancer: A population-based study National Health Insurance data for 166,848 patients in South Korea from 2010 to 2020고영휘Article
2022Multiple primary cancers in men with sporadic or familial prostate cancer: Its clinical implications김명Article
2026Prostate cancer in Korea: Nationwide trends in prevalence and medication use during 2011–2021이한길Article
2025Risk of Alzheimer’s disease and Parkinson’s disease following androgen deprivation therapy in a real world nationwide cohort이한길Article
2022Robot-assisted radical prostatectomy in the treatment of patients with clinically high-risk localized and locally advanced prostate cancer: single surgeons functional and oncologic outcomes신태영Article
2018Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6송완Article
2018The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: An observational cross-sectional study송완Article
2015The prognostic effect of prostate-specific antigen half-life at the first follow-up visit in newly diagnosed metastatic prostate cancer김광현Article
2026Utility of prostate-specific antigen derivatives to minimize unnecessary magnetic resonance imaging in patients with prior negative prostate biopsy류호영Article
2021Who can safely evade a magnetic resonance imaging fusion-targeted biopsy (MRIFTB) for prostate imaging reporting and data system (PI-RADS) 3 lesion?김명; 류호영Article

BROWSE